ArticleCommunications engineering2025
3D vector field-guided toolpathing for 3D bioprinting.
Article in Communications engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editors' Choice 2025.Communications engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex fibrous microarchitectures are common in biology, with fiber orientation playing a key role in the structure-function relationships that govern tissue behavior. Directional imaging modalities, such as diffusion tensor magnetic resonance imaging (DTMRI), can be used to derive a 3D vector map of fiber orientation. Incorporating this alignment information into engineered tissues remains a challenging and evolving area of research, with direct incorporation of directional imaging data into engineered tissue structures yet to be achieved. Here we describe an algorithmic framework, entitled Nonplanar, Architecture-Aligned Toolpathing for In Vitro 3D bioprinting (NAATIV3), which processes DTMRI data to map tissue fibers, reduce them to a representative subset, remove conflicting fibers, select a printable sequence, and output a G-code file. DTMRI data from a human left ventricle was used to 3D print fibered models with high accuracy. It is anticipated that NAATIV3 is generalizable beyond the cardiac application demonstrated here. Directional imaging data from a variety of organs, disease states, and developmental timepoints may be processible by NAATIV3, enabling the creation of models for understanding development, physiology, and pathophysiology. Furthermore, the NAATIV3 framework could be extended to bioengineered food manufacturing, plant engineering, and beyond.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.